Here, we analyzed the expression of FHOD1 and FMNL1 in intestinal-type tumor samples of the stomach, gastrointestinal junction and distal esophagus and investigated their association with clinical data, including GC molecular subtypes. This evidence concerns the gene FHOD1 and neoplasm.